Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Most eye cancers are melanomas (also known as ocular melanomas or intraocular melanomas). Some of these might be brought to a doctor’s attention because of signs or symptoms a person is having. But not all eye cancers cause symptoms, and sometimes these cancers are found during eye exams or on tests.
If you have an abnormal area on your eye that might be cancer, your doctor will examine it and might do tests to find out if it is melanoma or some other eye condition.
If you’re being seen by your primary doctor and eye cancer is suspected, you may be referred to an ophthalmologist, a medical doctor who specializes in eye diseases, who will look at the area more closely.
There are many tests used for diagnosing eye melanoma. Not everyone will need all of the tests described here. The tests you may need will depend on:
If eye cancer is found, more tests might be done to learn more about it and whether it has spread to other areas of the body.
Usually, the first step in diagnosing eye melanoma is an exam by an ophthalmologist. The doctor will:
To get a good look inside the eye, the ophthalmologist may dilate the pupil with eyedrops and use special tools:
If an eye exam suggests you might have eye cancer, more tests such as imaging tests or other procedures might be done to confirm the diagnosis.
Imaging tests use sound waves, x-rays, magnetic fields, or radioactive particles to create pictures of the inside of your body. These tests might be done for different reasons, including:
Ultrasound is a very common test to help diagnose eye melanomas. It uses sound waves and their echoes to make pictures of organs and structures in the body.
For this test, a small wand-like instrument is placed up against the eyelid or eyeball. It sends sound waves through the eye and picks up the echoes as they bounce back. The echoes are converted into an image on a computer screen.
This test is very useful for diagnosing eye melanomas because they tend to look a certain way on ultrasound. Using this test, doctors can confirm a diagnosis of melanoma of the eye in most cases. This test can also show the location and size of the tumor.
Ultrasound biomicroscopy (UBM): This is a special type of ultrasound that uses high-energy sound waves to create very detailed images of the front parts of the eye.
If you have already been diagnosed with eye melanoma, an ultrasound of your abdomen (belly) may be done to look for tumors in the liver, which is a common site of spread of this cancer.
This test is similar to an ultrasound, but it uses light waves instead of sound waves to create very detailed images of the back of the eye.
For this test, an orange, fluorescent dye (fluorescein) is injected into your bloodstream through a vein in the arm. Pictures of the back of the eye are then taken using a special light that makes the dye fluoresce (glow). This lets the doctor see the blood vessels inside the eye.
MRI scans use radio waves and strong magnets instead of x-rays to make detailed pictures of the inside of the body. MRI can be very helpful when looking at eye tumors. It can sometimes help tell if an abnormal area is a melanoma, as well as show how far the tumor has grown into nearby structures.
If eye melanoma is found, an MRI might also be done on other parts of the body to look for spread of the cancer to places like the liver.
A CT scan combines many x-rays to make detailed cross-sectional images of parts of the body. This scan is sometimes used to look for spread of the cancer to other parts of the body, such as the lungs or the liver.
For most cancer types, the diagnosis of cancer is made by removing a small piece of the tumor and looking at it in the lab for cancer cells. This is known as a biopsy.
A biopsy is often not needed to diagnose eye melanomas because they can usually be diagnosed based on the results of a thorough eye exam and imaging tests. But a biopsy might still be needed in some situations if the results of exams and tests aren’t clear.
Even if eye melanoma has already been diagnosed, a biopsy might still be done to check the cancer cells for certain gene or chromosome changes that can help predict the chance of the cancer spreading to other parts of the body. This might affect a person’s treatment options (including if they’re eligible for certain clinical trials), as well as how often they should be seen after treatment. (See below for more on this.)
While many people with melanoma of the eye are treated without having a biopsy first, your doctor may advise a biopsy depending on your specific situation. They can discuss the risks and benefits of the procedure with you.
If a biopsy is needed, it can be done either with sedation and local anesthesia (numbing medicine) or while you are under general anesthesia (in a deep sleep).
Different types of biopsies can be done for eye melanoma, depending on where the abnormal area is in the eye:
Newer biopsy techniques can help lower the chances of tumor cells leaking or spreading along the needle path, so the cancer doesn't spread within or outside the eye.
For uveal melanoma, tests that look at certain genes and chromosomes inside the cancer cells can provide information about how likely the cancer is to spread from the eye to other parts of the body. Tests may include:
Cytogenetic testing: This type of test looks for changes in certain chromosomes, including chromosomes 3, 6, and 8. This can help predict how likely a uveal tumor is to spread (metastasize). For example, uveal melanomas that spread often have only one copy of chromosome 3 (known as monosomy 3).
Testing for specific gene changes: Mutations in the BAP1 gene, which is located on chromosome 3, are also linked with a high risk of metastasis. Mutations in the SF3B1 and EIF1AX genes are linked with a lower risk of spread.
Gene expression profiling: These tests look at patterns of genes within the cells. For example, the DecisionDx-UM test looks for certain patterns that show how likely an eye melanoma is to spread:
These tests can help a person understand their risk for the cancer growing and spreading. They might also influence how closely the person is monitored during and after treatment.
Before your treatment begins, talk with your doctor about the risks and benefits of having one of these tests and what the results might mean for your care.
See What's New in Eye Cancer Research? for more information.
A liquid biopsy is a newer way to collect cancer cells for testing without having to make a cut or put a needle into the eye. Instead, melanoma cells can sometimes be collected from a blood sample. But liquid biopsies are still being researched and not done routinely yet for eye cancers. For more on this, see What’s New in Eye Cancer Research?
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Carvajal RD, Harbour JW. Metastatic uveal melanoma. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/metastatic-uveal-melanoma on April 9, 2025.
Grisanti S, Tura A. Uveal Melanoma. In Scott JF, Gerstenblith MR, eds. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018. Accessed at https://www.ncbi.nlm.nih.gov/books/NBK506988/ on April 9, 2025.
Harbour JW, Shih HA. Initial management of uveal and conjunctival melanomas. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/initial-management-of-uveal-and-conjunctival-melanomas on April 9, 2025.
Houghton O, Gordon K. Chapter 64: Ocular Tumors. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2025.
National Cancer Institute. Intraocular (Uveal) Melanoma Treatment (PDQ®)–Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq on April 9, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Melanoma: Uveal. V.1.2025. Accessed at https://www.nccn.org on April 9, 2025.
Sullivan RJ, Shoushtari AN. The molecular biology of melanoma. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/the-molecular-biology-of-melanoma on April 9, 2025.
Last Revised: May 5, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.